LFG
TRAW icon

Larson Financial Group’s Traws Pharma TRAW Stock Holding History

Larson Financial Group’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3
Closed -$48 – 1636
2023
Q1 		$48 Hold
3
– – ﹤0.01% 1518
2022
Q4 		$43 Hold
3
– – ﹤0.01% 1477
2022
Q3 		$0 Hold
3
– – ﹤0.01% 1416
2022
Q2 		$0 Hold
3
– – ﹤0.01% 1309
2022
Q1 		$0 Hold
3
– – ﹤0.01% 1188
2021
Q4 		$0 Hold
3
– – ﹤0.01% 1189
2021
Q3 		$0 Hold
3
– – ﹤0.01% 961
2021
Q2 		$0 Hold
3
– – ﹤0.01% 956
2021
Q1 		$1K Hold
3
– – ﹤0.01% 811
2020
Q4 		$0 Hold
3
– – ﹤0.01% 868
2020
Q3 		$0 Hold
3
– – ﹤0.01% 849
2020
Q2 		$1K Buy
+3
New +$458 ﹤0.01% 664

Other funds holding TRAW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Larson Financial Group's TRAW Position: Q2 2023 in Review

Larson Financial Group sold out of Traws Pharma (TRAW) in Q2 2023, closing a stake of 3 shares — an estimated $48 sold.

Larson Financial Group first reported a position in TRAW in Q2 2020 and held it in 12 quarters. The position peaked at $1K in Q1 2021. 23 funds tracked by Wall St. Rank hold TRAW as of Q2 2023.

  • Larson Financial Group reported no remaining Traws Pharma position as of Q2 2023 after selling out during the quarter.
  • Larson Financial Group sold 3 Traws Pharma shares in Q2 2023, an estimated $48.
  • Larson Financial Group first reported a position in Traws Pharma in Q2 2020 and held it in 12 quarters.
  • Larson Financial Group's Traws Pharma position peaked at $1K in Q1 2021.
  • 23 funds tracked by Wall St. Rank held Traws Pharma as of Q2 2023.

Based on Larson Financial Group's 13F filing for Q2 2023, filed 3 Aug 2023.